FOXO Technologies (FOXO) has signed a non-binding agreement to acquire Vector Biosource. Vector is an information and biospecimen sourcing ...
FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), announces that it has signed a non-binding agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information and biospecimen ...
Enables AI platform to model and predict patient outcomes on historical samples Global biospecimen market valued at $4.4 billion in 2023, expected to grow at an annual CAGR of more than 13% ...
A researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has ...
Biopreservation Market The Biopreservation market Growth is expected to reach USD 6.01 Billion at a CAGR 11.5% during the forecast period 2 ...